India, mad over EU ban on drugs, postpones trade talks

India has lashed out at the European Union, miffed over the EU ban of more than 700 drugs after finding issues in the clinical trials conducted by India's GVK BioSciences. The trade ministry has said it will defer trade talks with Europe because it is "disappointed and concerned" over the ban. The negotiations were slated to begin this month. The ban by the European Medicines Agency affects both Indian and European companies, but is expected to cost India $1 billion or more in exports. More from FiercePharmaAsia

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.